E. Trent

Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy

S. Mandl, Susan P. Foy, R. Rountree, 2014, Journal of Immunotherapy for Cancer.

Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells

S. Mandl, Susan P. Foy, R. Rountree, 2016, Cancer Immunology, Immunotherapy.

Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer

S. Mandl, Susan P. Foy, R. Rountree, 2014, Journal of Immunotherapy for Cancer.

Magnitude and quality of tumor-infiltrating T-cell response upon poxvirus-based active immunotherapy alone and in combination with CTLA-4 immune checkpoint inhibition.

S. Mandl, Susan P. Foy, R. Rountree, 2014 .